Pharmacies are currently preparing for the introduction of the Falsified Medicines Directive (FMD) which comes into force on 9th February 2019. As part of this preparation, AIS Ltd have supplied 1800 pharmacies with barcode scanners.
What this means for consumers, is that a unique identifier, which is scanned at the point of purchase, 
along with anti-tampering packaging, will guarantee medicine authenticity and will strengthen the security of the medicine supply chain - from manufacturers to distributors to pharmacies and hospitals.
The safety features will help protect consumers in Ireland and across Europe against the threat of falsified medicines, which may contain ingredients, including active ingredients, which are of low quality or in the wrong dosage and could potentially put patients’ health at risk.
Simon Smyth, Managing Director of AIS Ltd commented that “We are proud to play our part in this important legislation which guarantees that potentially harmful medicines cannot reach the general public via legitimate supply channels. Our ISO-9000-2015 accreditation along with our dedicated team, ensured that supplying barcode scanners to 1800 pharmacies was done swiftly and efficiently. We are seeing more and more enquiries from this sector as the February 2019 deadline for compliance approaches”.
AIS has also seen an increase in tamper evident labelling machines sold to larger pharmaceutical/medical device clients which ensures that goods are packaged with a tamper evident label before entering the supply chain.